These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 35464395)

  • 21. Design of multi-epitope peptides containing HLA class-I and class-II-restricted epitopes derived from immunogenic Leishmania proteins, and evaluation of CD4+ and CD8+ T cell responses induced in cured cutaneous leishmaniasis subjects.
    Hamrouni S; Bras-Gonçalves R; Kidar A; Aoun K; Chamakh-Ayari R; Petitdidier E; Messaoudi Y; Pagniez J; Lemesre JL; Meddeb-Garnaoui A
    PLoS Negl Trop Dis; 2020 Mar; 14(3):e0008093. PubMed ID: 32176691
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Unlocking the potential of microfluidics in mass spectrometry-based immunopeptidomics for tumor antigen discovery.
    Stutzmann C; Peng J; Wu Z; Savoie C; Sirois I; Thibault P; Wheeler AR; Caron E
    Cell Rep Methods; 2023 Jun; 3(6):100511. PubMed ID: 37426761
    [TBL] [Abstract][Full Text] [Related]  

  • 23. T Cell Epitope Discovery in the Context of Distinct and Unique Indigenous HLA Profiles.
    Hensen L; Illing PT; Rowntree LC; Davies J; Miller A; Tong SYC; Habel JR; van de Sandt CE; Flanagan KL; Purcell AW; Kedzierska K; Clemens EB
    Front Immunol; 2022; 13():812393. PubMed ID: 35603215
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dendritic cell-based immunotherapy for colon cancer using an HLA-A*0201-restricted cytotoxic T-lymphocyte epitope from tumor-associated antigen 90K.
    Hee Lee J; Park MS; Hwang JE; Cho SH; Bae WK; Shim HJ; Kim DE; Chung IJ
    Cell Mol Immunol; 2013 May; 10(3):275-82. PubMed ID: 23524651
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Current perspectives on mass spectrometry-based immunopeptidomics: the computational angle to tumor antigen discovery.
    Zhang B; Bassani-Sternberg M
    J Immunother Cancer; 2023 Oct; 11(10):. PubMed ID: 37899131
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cyclin-dependent kinaselike 5 is a novel target of immunotherapy in adult T-cell leukemia.
    Kawahara M; Hori T; Matsubara Y; Okawa K; Uchiyama T
    J Immunother; 2007; 30(5):499-505. PubMed ID: 17589290
    [TBL] [Abstract][Full Text] [Related]  

  • 27. BCR-ABL fusion regions as a source of multiple leukemia-specific CD8+ T-cell epitopes.
    Kessler JH; Bres-Vloemans SA; van Veelen PA; de Ru A; Huijbers IJ; Camps M; Mulder A; Offringa R; Drijfhout JW; Leeksma OC; Ossendorp F; Melief CJ
    Leukemia; 2006 Oct; 20(10):1738-50. PubMed ID: 16932347
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Direct interrogation of viral peptides presented by the class I HLA of HIV-infected T cells.
    Yaciuk JC; Skaley M; Bardet W; Schafer F; Mojsilovic D; Cate S; Stewart CJ; McMurtrey C; Jackson KW; Buchli R; Olvera A; Cedeño S; Plana M; Mothe B; Brander C; West JT; Hildebrand WH
    J Virol; 2014 Nov; 88(22):12992-3004. PubMed ID: 25165114
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Application of mass spectrometry-based MHC immunopeptidome profiling in neoantigen identification for tumor immunotherapy.
    Zhang X; Qi Y; Zhang Q; Liu W
    Biomed Pharmacother; 2019 Dec; 120():109542. PubMed ID: 31629254
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antigen identification for HLA class I- and HLA class II-restricted T cell receptors using cytokine-capturing antigen-presenting cells.
    Lee MN; Meyerson M
    Sci Immunol; 2021 Jan; 6(55):. PubMed ID: 33483338
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Spatiotemporal Differences in Presentation of CD8 T Cell Epitopes during Hepatitis B Virus Infection.
    Khakpoor A; Ni Y; Chen A; Ho ZZ; Oei V; Yang N; Giri R; Chow JX; Tan AT; Kennedy PT; Maini M; Urban S; Bertoletti A
    J Virol; 2019 Feb; 93(4):. PubMed ID: 30518652
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Apparent Lack of
    Kemps PG; Zondag TC; Steenwijk EC; Andriessen Q; Borst J; Vloemans S; Roelen DL; Voortman LM; Verdijk RM; van Noesel CJM; Cleven AHG; Hawkins C; Lang V; de Ru AH; Janssen GMC; Haasnoot GW; Franken KLMC; van Eijk R; Solleveld-Westerink N; van Wezel T; Egeler RM; Beishuizen A; van Laar JAM; Abla O; van den Bos C; van Veelen PA; van Halteren AGS
    Front Immunol; 2019; 10():3045. PubMed ID: 31998317
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immunization with a peptide containing MHC class I and II epitopes derived from the tumor antigen SIM2 induces an effective CD4 and CD8 T-cell response.
    Kissick HT; Sanda MG; Dunn LK; Arredouani MS
    PLoS One; 2014; 9(4):e93231. PubMed ID: 24690990
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Isolation of T cell receptors targeting recurrent neoantigens in hematological malignancies.
    Tubb VM; Schrikkema DS; Croft NP; Purcell AW; Linnemann C; Freriks MR; Chen F; Long HM; Lee SP; Bendle GM
    J Immunother Cancer; 2018 Jul; 6(1):70. PubMed ID: 30001747
    [TBL] [Abstract][Full Text] [Related]  

  • 35. CD8
    Qiu C; Xiao C; Wang Z; Zhu G; Mao L; Chen X; Gao L; Deng J; Su J; Su H; Fang EF; Zhang ZJ; Zhang J; Xie C; Yuan J; Luo OJ; Huang LA; Wang P; Chen G
    Front Immunol; 2021; 12():764949. PubMed ID: 35116022
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identification and characterization of epitopes of the receptor for hyaluronic acid-mediated motility (RHAMM/CD168) recognized by CD8+ T cells of HLA-A2-positive patients with acute myeloid leukemia.
    Greiner J; Li L; Ringhoffer M; Barth TF; Giannopoulos K; Guillaume P; Ritter G; Wiesneth M; Döhner H; Schmitt M
    Blood; 2005 Aug; 106(3):938-45. PubMed ID: 15827130
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Recent Advances in Lung Cancer Immunotherapy: Input of T-Cell Epitopes Associated With Impaired Peptide Processing.
    Leclerc M; Mezquita L; Guillebot De Nerville G; Tihy I; Malenica I; Chouaib S; Mami-Chouaib F
    Front Immunol; 2019; 10():1505. PubMed ID: 31333652
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Development of a CD8 co-receptor independent T-cell receptor specific for tumor-associated antigen MAGE-A4 for next generation T-cell-based immunotherapy.
    Davari K; Holland T; Prassmayer L; Longinotti G; Ganley KP; Pechilis LJ; Diaconu I; Nambiar PR; Magee MS; Schendel DJ; Sommermeyer D; Ellinger C
    J Immunother Cancer; 2021 Mar; 9(3):. PubMed ID: 33771892
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Efficiency and mechanism of antigen-specific CD8+ T-cell activation using synthetic long peptides.
    Zandvliet ML; Kester MG; van Liempt E; de Ru AH; van Veelen PA; Griffioen M; Guchelaar HJ; Falkenburg JH; Meij P
    J Immunother; 2012; 35(2):142-53. PubMed ID: 22306902
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Soluble HLA peptidome of pleural effusions is a valuable source for tumor antigens.
    Khazan-Kost S; Cafri G; Melamed Kadosh D; Mooshayef N; Chatterji S; Dominissini D; Manor S; Zisser B; Broday L; Talalai E; Shemer A; Zadok O; Ofek E; Onn A; Admon A; Peled M
    J Immunother Cancer; 2022 May; 10(5):. PubMed ID: 35580925
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.